- Home
- SMX vs BDRX Comparison
SMX vs BDRX Comparison
Compare SMX & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMX
- BDRX
- Stock Information
- Founded
- SMX N/A
- BDRX 2000
- Country
- SMX Ireland
- BDRX United Kingdom
- Employees
- SMX N/A
- BDRX N/A
- Industry
- SMX Industrial Machinery/Components
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- SMX Technology
- BDRX Health Care
- Exchange
- SMX Nasdaq
- BDRX Nasdaq
- Market Cap
- SMX 2.9M
- BDRX 3.2M
- IPO Year
- SMX N/A
- BDRX N/A
- Fundamental
- Price
- SMX $4.42
- BDRX $3.96
- Analyst Decision
- SMX
- BDRX
- Analyst Count
- SMX 0
- BDRX 0
- Target Price
- SMX N/A
- BDRX N/A
- AVG Volume (30 Days)
- SMX 1.0M
- BDRX 175.1K
- Earning Date
- SMX 01-01-0001
- BDRX 09-12-2025
- Dividend Yield
- SMX N/A
- BDRX N/A
- EPS Growth
- SMX N/A
- BDRX N/A
- EPS
- SMX N/A
- BDRX N/A
- Revenue
- SMX N/A
- BDRX N/A
- Revenue This Year
- SMX N/A
- BDRX N/A
- Revenue Next Year
- SMX N/A
- BDRX N/A
- P/E Ratio
- SMX N/A
- BDRX N/A
- Revenue Growth
- SMX N/A
- BDRX N/A
- 52 Week Low
- SMX $3.12
- BDRX $3.58
- 52 Week High
- SMX $66,187.38
- BDRX $92.00
- Technical
- Relative Strength Index (RSI)
- SMX 60.83
- BDRX 35.26
- Support Level
- SMX $3.12
- BDRX $3.58
- Resistance Level
- SMX $5.99
- BDRX $5.74
- Average True Range (ATR)
- SMX 0.73
- BDRX 0.49
- MACD
- SMX 0.31
- BDRX -0.14
- Stochastic Oscillator
- SMX 53.92
- BDRX 27.63
About SMX SMX (Security Matters) Public Limited Company
SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.